The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Provalis's sole in-house lawyer has been made redundant following the struggling company's decision to put itself into liquidation.
Legal director Lee Greenbury will be leaving the pharmaceutical and medical diagnostics business at the end of the September after eight years.
Greenbury joined Provalis in July 1998 following a spell at high street chemist Boots. He will stay on as director of some of the company's subsidiaries throughout the liquidation process. The liquidation of the company is subject to a shareholder vote scheduled for 5 September.
Provalis's decision to go into voluntary liquidation follows the sale of its pharmaceuticals business to Kogen for £10.5m earlier this year. The company has also decided to sell its remaining diabetes testing business. The move follows technical problems with its in2it diabetes monitor and disappointing sales at its pharmaceuticals business.